In Sickle Cell Project, Baylor Scientist Discovers Link to Fetal Hemoglobin Production with Ingenuity Variant Analysis from QIAGEN
27 Oct 2014Just two decades ago, there were virtually no therapeutic treatments for patients with sickle cell anemia, a severe condition in which blood cells form rigid sickle shapes, damaging several organs in the body. Today, there’s not only a medication, but thanks to new research from Vivien Sheehan and data interpretation from QIAGEN’s Ingenuity Variant Analysis, scientists also have a promising new lead for another treatment option.
Related Products
Request Quote for All Products
Variant Analysis
Ingenuity Systems Inc.Identify causal variants from human sequencing data in just hours Rapidly Identify and Prioritize Variants Ingenuity Variant Analysis combines analytical tools and integrated content to help you rapidly identify and prioritize variants by drilling down to a small, targeted subset of compelling variants based both upon published biological evidence and your own knowledge of disease biology. Biological Interpretation of your Variant Data With Variant Analysis, you can interrogate your variants from multiple biological perspectives, explore different biological hypotheses, and identify the most promising variants for follow-up.